Sotac Pharmaceuticals

Sotac Pharmaceuticals EPS

The Earnings per Share (EPS) of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 19, 2026 is 7.26 INR. In the previous year, Earnings per Share (EPS) was 3.24 INR — a change of 124.25% (higher).

EPS

7.26INR

YoY

124.25%

Last updated:

Earnings per Share (EPS) of Sotac Pharmaceuticals is 2025 7.26 INR. Earnings per Share (EPS) of Sotac Pharmaceuticals was 2024 3.24 INR. It decreases by 124.25% higher compared to the previous year.

The Sotac Pharmaceuticals EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
0.08 INR
Jan 1, 2021
-2.14 INR
Jan 1, 2022
2.61 INR
Jan 1, 2023
4.07 INR
Jan 1, 2024
3.24 INR
Jan 1, 2025
7.26 INR
The Sotac Pharmaceuticals EPS history
YEAREPSYoY
7.26INR+124.25%
3.24INR-20.38%
4.07INR+56.17%
2.61INR-221.70%
-2.14INR-2,803.31%
0.08INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

Earnings per Share (EPS) of Sotac Pharmaceuticals is 7.26 INR in 2025.

Earnings per Share (EPS) of Sotac Pharmaceuticals changed from 3.24 INR to 7.26 INR, representing a 124.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sotac Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sotac Pharmaceuticals